. (2015). The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment. Open Heart. http://doi.org/10.1136/openhrt-2015-000272
S. Weng
First name
S.
Middle name
F.
Last name
Weng
. (2015). Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT). Atherosclerosis. http://doi.org/10.1016/j.atherosclerosis.2014.12.034
. (2017). Can machine-learning improve cardiovascular risk prediction using routine clinical data?. PLoS One. http://doi.org/10.1371/journal.pone.0174944
. (2019). Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease. Heart. http://doi.org/10.1136/heartjnl-2018-314253
. (2019). The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. http://doi.org/10.1186/s12916-019-1373-y
. (2020). Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care. NPJ Digit Med. http://doi.org/10.1038/s41746-020-00349-5
. (2021). Sex, Age, and Socioeconomic Differences in Nonfatal Stroke Incidence and Subsequent Major Adverse Outcomes. Stroke. http://doi.org/10.1161/strokeaha.120.031659
. (2021). Sex disparity in subsequent outcomes in survivors of coronary heart disease. Heart. http://doi.org/10.1136/heartjnl-2021-319566
. (2021). Obesity and long-term outcomes after incident stroke: a prospective population-based cohort study. J Cachexia Sarcopenia Muscle. http://doi.org/10.1002/jcsm.12818
. (2021). Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease. PLoS One. http://doi.org/10.1371/journal.pone.0260839